Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

The road to lenacapavir, a breakthrough HIV treatment

Written by | 26 May 2025

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be… read more.

ViiV Healthcare to present latest advances in HIV treatment and prevention at CROI 2025

Written by | 16 Mar 2025

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting abstracts from its innovative HIV… read more.

Simplified HIV treatment options just as effective: Major clinical trial

Written by | 24 Feb 2023

Two newer simplified treatment options are at least as effective as current approaches, according to the results of a world-first international clinical trial into second-line HIV therapy led… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.